Home
About
Overview
Sharing Data
ORCID
Help
History (9)
RNA Interference With Zilebesiran for Mild to Moderate Hypertension: The KARDIA-1 Randomized Clinical Trial.
Aggregating and disaggregating patients in clinical trials and their subgroup analyses.
Degradation of FBXO31 by APC/C is regulated by AKT- and ATM-mediated phosphorylation.
Recognition of hypertrophic cardiomyopathy as a contemporary, relatively common, and treatable disease (from the International Summit V).
Medical management of premenstrual dysphoric disorder.
See All 9 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Medical management of premenstrual dysphoric disorder.
Yonkers KA. Medical management of premenstrual dysphoric disorder. J Gend Specif Med. 1999 May-Jun; 2(3):55-60.
View in:
PubMed
subject areas
Affective Symptoms
Alprazolam
Anti-Anxiety Agents
Antidepressive Agents
Female
Humans
Premenstrual Syndrome
Progesterone Congeners
authors with profiles
Kimberly A Yonkers MD